InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Rummelt Andreas, Director. Director active across 2 companies, notably ALEXION PHARMACEUTICALS, INC.. Cumulatively, 4 filings have been published. History available since 20 May 2021. The latest transaction was disclosed on 21 July 2021 (Disposition). Regulator: SEC (Form 4). The full history is openly available.
Declarations4 total
28,109 shares0Common Stock, par value $.0001 per shareSEC:0000899866-21-000064
28,109 shares0Common Stock, par value $.0001 per shareSEC:0000899866-21-000064:0
1,962 shares0Common Stock, par value $.0001 per shareSEC:0000899866-21-000045
1,962 shares0Common Stock, par value $.0001 per shareSEC:0000899866-21-000045:0
4 of 4 declarations
About Rummelt Andreas
Andreas Rummelt is a Board Member at Alexion Pharmaceuticals, Inc., a company specializing in innovative therapies for rare diseases. As a board member, he participates in the governance of the company and in shaping its strategy. His expertise in the pharmaceutical sector is a valuable asset for Alexion in its mission to improve patients' lives.
